ArticleFrontiers in pediatrics2026
Impact of the neonatal intensive critical ultrasound workflow for managing neonatal acute pulmonary hypertension.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the value of developed the Neonatal Intensive Critical Ultrasound (NICUltra) Examination workflow in the management of neonatal acute pulmonary hypertension (aPH). Methods: In this retrospective cohort study, we assessed the effects of NICUltra-guided care on neonates with early aPH who underwent inhaled nitric oxide (iNO) therapy. The primary outcomes were the durations of iNO treatment and mechanical ventilation. Results: Of the 77 enrolled neonates, 36 (46.7%) received NICUltra-guided care. Compared with non-NICUltra-guided patients, NICUltra-guided patients had significantly shorter durations of iNO treatment ( Conclusion: Among neonates >32 weeks with early aPH receiving iNO treatment and without structural cardiopulmonary anomalies in a single-center retrospective study, the implementation of the NICUltra workflow is associated with significantly improved clinical efficacy and may be useful for optimizing clinical strategies with no observed differences in short-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.